Therapeutic potential of Dioscorea extract (DA-9801) in comparison with alpha lipoic acid on the peripheral nerves in experimental diabetes

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Jin, Heung Yong ^a   Kim, Sun Hee ^a   Yu, Hea Min ^b   Baek, Hong Sun ^a   Park, Tae Sun ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Eulji University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DA 9801; DIOSCOREA JAPONICA EXTRACT; DIOSCOREA NIPPONICA EXTRACT; GLUCOSE; INTERLEUKIN 6; NERVE GROWTH FACTOR; PLANT EXTRACT; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG POTENCY; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL CORD; STREPTOZOCIN DIABETES; TACTILE STIMULATION; THERMAL STIMULATION; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION; WESTERN BLOTTING;

EID: 84879333421     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/631218     Document Type: Article

References (32)

1. Vinik A. I., Vinik E., Prevention of the complications of diabetes. American Journal of Managed Care 2003 9 3 S63 S80 2-s2.0-0037354588 (Pubitemid 36401621)
2. Nicholson B., Differential diagnosis: nociceptive and neuropathic pain. American Journal of Managed Care 2006 12 9 S256 S262 2-s2.0-33745615880 (Pubitemid 43993103)
3. Vinik A. I., Park T. S., Stansberry K. B., Pittenger G. L., Diabetic neuropathies. Diabetologia 2000 43 8 957 973 2-s2.0-0033837950 10.1007/s001250051477 (Pubitemid 30655714)
4. Tesfaye S., Advances in the management of diabetic peripheral neuropathy. Current Opinion in Supportive and Palliative Care 2009 3 2 136 143 2-s2.0-67651235626 10.1097/SPC.0b013e32832b7df5
5. Apfel S. C., Neurotrophic factors and diabetic peripheral neuropathy. European Neurology 1999 41 1 27 34 2-s2.0-0032981906 (Pubitemid 29099612)
6. Colangelo A. M., Bianco M. R., Vitagliano L., Cavaliere C., Cirillo G., De Gioia L., Diana D., Colombo D., Redaelli C., Zaccaro L., Morelli G., Papa M., Sarmientos P., Alberghina L., Martegani E., A new nerve growth factor-mimetic peptide active on neuropathic pain in rats. Journal of Neuroscience 2008 28 11 2698 2709 2-s2.0-40849083920 10.1523/JNEUROSCI.5201-07.2008 (Pubitemid 351398884)
7. Kim N., Kim S. H., Kim Y. J., Neurotrophic activity of DA-9801, a mixture extract of Dioscorea japonica Thunb. and Dioscorea nipponica Makino, in vitro. Journal of Ethnopharmacology 2011 137 1 312 319 10.1016/j.jep.2011.05.032
8. Choi S. Z., Son M. W., A novel botanical drug for the treatment of diabetic neuropathy. Archives of Pharmacal Research 2011 34 6 865 867 2-s2.0-79960263015 10.1007/s12272-011-0621-2
9. Chaplan S. R., Bach F. W., Pogrel J. W., Chung J. M., Yaksh T. L., Quantitative assessment of tactile allodynia in the rat paw. Journal of Neuroscience Methods 1994 53 1 55 63 2-s2.0-0027933374 10.1016/0165-0270(94) 90144-9 (Pubitemid 24238751)
10. Zor T., Selinger Z., Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Analytical Biochemistry 1996 236 2 302 308 2-s2.0-0029917011 10.1006/abio.1996.0171 (Pubitemid 26136110)
11. Jin H. Y., Liu W. J., Park J. H., Baek H. S., Park T. S., Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats. Archives of Medical Research 2009 40 7 536 544 2-s2.0-71649102751 10.1016/j.arcmed.2009.09.005
12. Asensio-Pinilla E., Udina E., Jaramillo J., Navarro X., Electrical stimulation combined with exercise increase axonal regeneration after peripheral nerve injury. Experimental Neurology 2009 219 1 258 265 2-s2.0-68549097830 10.1016/j.expneurol.2009.05.034
13. Gordon Smith A., Robinson Singleton J., Idiopathic neuropathy, prediabetes and the metabolic syndrome. Journal of the Neurological Sciences 2006 242 1-2 9 14 2-s2.0-33644542482 10.1016/j.jns.2005.11.020
14. Gordois A., Scuffham P., Shearer A., Oglesby A., Tobian J. A., The health care costs of diabetic peripheral neuropathy in the U.S. Diabetes Care 2003 26 6 1790 1795 2-s2.0-0043095569 10.2337/diacare.26.6.1790 (Pubitemid 36929121)
15. Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M., Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews 2002 23 5 599 622 2-s2.0-0036796875 10.1210/er.2001-0039 (Pubitemid 35191625)
16. Obrosova I. G., Drel V. R., Pacher P., Ilnytska O., Wang Z. Q., Stevens M. J., Yorek M. A., Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 2005 54 12 3435 3441 2-s2.0-33644681565 10.2337/diabetes.54. 12.3435 (Pubitemid 43334333)
17. Giugliano D., Ceriello A., Paolisso G., Oxidative stress and diabetic vascular complications. Diabetes Care 1996 19 3 257 267 2-s2.0-0030048496 (Pubitemid 26070354)
18. Ceriello A., Morocutti A., Mercuri F., Quagliaro L., Moro M., Damante G., Viberti G. C., Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 2000 49 12 2170 2177 2-s2.0-0033651497
19. Levi-Montalcini R., The nerve growth factor 35 years later. Science 1987 237 4819 1154 1162 2-s2.0-0023236055 (Pubitemid 17124912)
20. Sotelo J. R., Horie H., Ito S., Benech C., Sango K., Takenaka T., An in vitro model to study diabetic neuropathy. Neuroscience Letters 1991 129 1 91 94 2-s2.0-0025818274 10.1016/0304-3940(91)90727-B
21. Apfel S. C., Schwartz S., Adornato B. T., Freeman R., Biton V., Rendell M., Vinik A., Giuliani M., Stevens J. C., Barbano R., Dyck P. J., Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. Journal of the American Medical Association 2000 284 17 2215 2221 2-s2.0-0034328085
22. Kakinoki B., Sekimoto S., Yuki S., Ohgami T., Sejima M., Yamagami K., Saito K. I., Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals. Diabetes 2006 55 3 616 621 2-s2.0-33644787196 (Pubitemid 43343217)
23. Kim M. J., Kim H. N., Kang K. S., Baek N. I., Kim D. K., Kim Y. S., Kim S. H., Jean B. H., Methanol extract of Dioscoreae Rhizoma inhibits pro-inflammatory cytokines and mediators in the synoviocytes of rheumatoid arthritis. International Immunopharmacology 2004 4 12 1489 1497 2-s2.0-4444274008 10.1016/j.intimp.2004.07.001 (Pubitemid 39200598)
24. Kwon C. S., Sohn H. Y., Kim S. H., Kim J. H., Son K. H., Lee J. S., Lim J. K., Kim J. S., Anti-obesity effect of Dioscorea nipponica makino with lipase-inhibitory activity in rodents. Bioscience, Biotechnology and Biochemistry 2003 67 7 1451 1456 2-s2.0-2442610654 (Pubitemid 39251780)
25. Ma C., Wang W., Chen Y. Y., Liu R. N., Wang R. F., Du L. J., Neuroprotective and antioxidant activity of compounds from the aerial parts of Dioscorea opposita. Journal of Natural Products 2005 68 8 1259 1261 2-s2.0-24744466701 10.1021/np050021c (Pubitemid 41291275)
26. Nowicki M., Kosacka J., Serke H., Bluher M., Spanel-Borowski K., Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome. Journal of Neuroscience Research 2012 90 1 122 131 10.1002/jnr.22728
27. Tesfaye S., Boulton A. J. M., Dyck P. J., Freeman R., Horowitz M., Kempler P., Lauria G., Malik R. A., Spallone V., Vinik A., Bernardi L., Valensi P., Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010 33 2285 2293 2-s2.0-79951689096 10.2337/dc10-er12a
28. Tesfaye S., Selvarajah D., Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes/Metabolism Research and Reviews 2012 28 supplement 1 8 14
29. Kaplan D. R., Martin-Zanca D., Parada L. F., Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 1991 350 6314 158 160 2-s2.0-0025797396 10.1038/350158a0 (Pubitemid 21912187)
30. Gill J. S., Connolly D. C., McManus M. J., Maihle N. J., Windebank A. J., Suramin induces phosphorylation of the high-affinity nerve growth factor receptor in PC12 cells and dorsal root ganglion neurons. Journal of Neurochemistry 1996 66 3 963 972 2-s2.0-0030024857 (Pubitemid 26065892)
31. Jankowski M. P., Koerber H. R., Neurotrophic factors and nociceptor sensitization. Translational Pain Research: From Mouse to Man 2010 chapter 2 Boca Raton, Fla, USA CRC Press
32. Apfel S. C., Neurotrophic factors in the therapy of diabetic neuropathy. American Journal of Medicine 1999 107 2 34S 42S 2-s2.0-0032869840 Planning